1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7076)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22468)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10529)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (296)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22468)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Vemurafenib has potent antitumor activity in patients with relapsed/refractory BRAF mutant hairy cell leukemia
    Meeting Abstract

    Park, J. H.; Chung, S. S.; Chung, Y. R.; Won, H.; Kim, E.; Saven, A.; Wadleigh, M.; Stone, R. M.; Barrientos, J. C.; Rai, K. R.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Impact of the intestinal microbiota on infections and survival following hematopoietic stem cell transplantation
    Meeting Abstract

    Pamer, E. G.; Taur, Y.; Jenq, R.; van den Brink, M. R. M.
    Blood (2014)

    Fulltext@MSK | Save
  • Type II inhibition of JAK2 with NVP-CHZ868 reverses type I JAK inhibitor persistence and demonstrates increased efficacy in MPN models
    Meeting Abstract

    Meyer, S. C.; Keller, M. D.; Koppikar, P.; Guryanova, O. A.; Kleppe, M.; McKenney, A. S.; Sellers, W. R.; Hofmann, F.; Baffert, F.; Gaul, C.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Distinct DNA methylation and expression profiles underlie CMML responsiveness to decitabine and uncover novel mechanism of resistance
    Meeting Abstract

    Meldi, K.; Qin, T. T.; Buchi, F.; Micol, J. B.; Sotzen, J.; Masala, E.; Allione, B.; Gioia, D.; Poloni, A.; Lunghi, M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • MLL exons 4-8 duplication in a patient with CALR-mutated essential thrombocythemia
    Meeting Abstract

    Mantha, S.; Levine, R. L.; Rampal, R. K.
    Blood (2014)

    Fulltext@MSK | Save
  • Dynamic contrast-enhanced magnetic resonance perfusion weighted imaging (DCE-MRI) and diffusion weighted imaging (DWI) for pharmacodynamic evaluation of carboxyamidotriazole orotate (CTO) and temozolomide in malignant glioma
    Meeting Abstract

    Magge, R.; Arevalo Perez, J.; Young, R.; Kaley, T.; Pentsova, E.; DeAngelis, L.; Diamond, E.; Mellinghoff, I.; Peck, K.; Anderson, B.; more...
    Neuro-Oncology (2014)

    Fulltext@MSK | Save
  • High dose daunorubicin improves survival in AML up to age 60, across all cytogenetic Risk groups including patients with unfavorable cytogenetic risk, and FLT3-ITD mutant AML: Updated analyses from Eastern Cooperative Oncology trial E1900
    Meeting Abstract

    Luskin, M. R.; Lee, J. W.; Fernandez, H. F.; Lazarus, H. M.; Rowe, J. M.; Tallman, M. S.; Paietta, E. M.; Litzow, M.; Abdel-Wahab, O.; Patel, J. P.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Results of the ECOG E1900 trial in younger adults with AML using an event free survival endpoint are concordant with results based on overall survival: Potential for a surrogate endpoint to facilitate rapid approval of therapies in AML
    Meeting Abstract

    Luskin, M. R.; Lee, J. W.; Fernandez, H. F.; Lazarus, H. M.; Rowe, J. M.; Tallman, M. S.; Paietta, E. M.; Litzow, M.; Abdel-Wahab, O.; Patel, J. P.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Loss of TET2 function in myelodysplastic syndrome results in intragenic hypermethylation and alterations in mRNA splicing
    Meeting Abstract

    Lord, A. M.; Clement, K.; Schneider, R. K.; Marie, M.; Chen, M. C.; Levine, R. L.; Mullally, A.; Galili, N.; Ali, A. M.; Raza, A.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • IL-22 is an intestinal stem cell growth factor, and IL-22 administration in vivo reduces morbidity and mortality in murine GvHD
    Meeting Abstract

    Lindemans, C. A.; Mertelsmann, A.; O'Connor, M. H.; Dudakov, J. A.; Jenq, R.; Velardi, E.; Young, L. F.; Smith, O. M.; Lawrence, G.; Luo, N.; more...
    Blood (2014)

    Fulltext@MSK | Save